APSR2026-236

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-033
P52
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1216165-46904-APSR-236.pdf_440269.pdf
Format: PDF Only
08. Lung Cancer
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Disni De Zoysa * National Hospital for Respiratory Diseases Respiratory Medicine Welisara Sri Lanka
Parami Munasinghe - National Hospital for Respiratory Diseases Respiratory Medicine Welisara Sri Lanka
Damith Rodrigo - National Hospital for Respiratory Diseases Respiratory Medicine Welisara Sri Lanka
Bodhika Samarasekera - National Hospital for Respiratory Diseases Respiratory Medicine Welisara Sri Lanka
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Disni
De Zoysa
disni.dezoysa04@gmail.com
+94711488957
31-40
Sri Lanka
Case Report
Pulmonary Spindle Cell Carcinoma: A Rare and Aggressive Pleural-Based Tumor with Rapid Progression.
Maximum 25 words
Abstract Content
 
 
 
 
Pulmonary spindle cell carcinoma (PSCC) is a uncommon and highly aggressive subtype of sarcomatoid carcinoma, accounting for approximately 0.2–0.3% of non-small cell lung cancers. Because of its rarity and morphological to other spindle cell neoplasms, PSCC poses significant diagnostic and therapeutic challenges. Radiologically, these tumours often present as large peripheral or pleural-based masses, frequently mimicking mesothelioma, metastatic disease, or infection.
A 54-year-old female presented with a one-month history of left-sided pleuritic chest pain. She had a prior history of endometrial carcinoma treated with total hysterectomy and bilateral salpingo-oophorectomy in 2024. Chest radiography revealed a large left-sided mass, and contrast-enhanced computed tomography (CECT) demonstrated a heterogeneously enhancing pleural-based mass along the anterior pleural membrane. Bronchoscopy was unremarkable. CT-guided biopsy showed a malignant spindle cell tumour. Immunohistochemistry confirmed the diagnosis of pulmonary spindle cell carcinoma, demonstrating expression of epithelial and mesenchymal markers consistent with sarcomatoid differentiation. The patient was commenced on systemic chemotherapy with docetaxel and gemcitabine. Her course was complicated by chemotherapy-induced cytopenia requiring colony-stimulating factor support. Despite completing four cycles, the disease progressed rapidly, and she developed respiratory failure, succumbing three months after diagnosis.
PSCC is an aggressive lung malignancy with a poor survival rate and limited benefit to standard chemotherapy. Accurate diagnosis requires histopathological and immunohistochemical evaluation to distinguish it from other pleural spindle cell tumors. Given its rapid progression and high mortality, further evaluation of new therapeutic approaches, including targeted therapy and immunotherapy, is essential to improving outcomes.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
pulmonary spindle cell tumours,sarcomatoid carcinoma,aggressive lung neoplasm
maximum 3 keywords and no abbreviations, separated by commas
The authors declare that there are no conflicts of interest related to this case report.All procedures performed were in accordance with institutional guidelines, and informed consent was obtained from the patient’s next of kin for publication of this case.
243